The business of pharmacogenomics
Nat Biotechnol
.
1998 Feb;16(2):209-10.
doi: 10.1038/nbt0298-209.
Author
A Persidis
1
Affiliation
1
Argonex Inc., Charlottesville, VA 22901, USA. apersidis@argonex.com
PMID:
9487533
DOI:
10.1038/nbt0298-209
No abstract available
MeSH terms
Drug Design*
Drug Industry
Humans
Pharmacogenetics*